title: [Tetracaine versus diclofenac in the treatment of pain following refractive photokeratectomy].
abstract: OBJECTIVE
  To compare the efficacy and safety of topical diclofenac and tetracaine in reducing ocular pain after photorefractive keratectomy.
  
  
  METHODS
  Ophthalmology Department, Minjoz Hospital, Besançon, France.
  
  
  METHODS
  Seventy-four patients were randomized to receive either tetracaine 1% or diclofenac 0.1% after undergoing PRK. Tetracaine was instilled at 30 minute intervals for 24 hours. Diclofenac was instilled four times a day for 3 days. All patients were allowed to use oral Diantalvic (paracetamol-noramidopyrine) as a rescue analgesic if the study medications failed to control the ocular pain. Visual analog pain charts were used to record pain levels every hour for 30 hours after surgery. A subjective questionnaire was to be completed by the patient to evaluate discomfort every day for 3 days. Computer analysis of photography performed at D0, D1, D3, was used to evaluate the rate of epithelial closure.
  
  
  RESULTS
  Women had significantly more pain. Patients in the diclofenac group had significantly less pain. No statistically significant difference was seen in the rate of epithelial closure.
  
  
  CONCLUSIONS
  Diclofenac is more effective than tetracaine to reduce ocular pain and functional symptoms.
authors.affiliation: Service d'Ophtalmologie, CHU Jean Minjoz, Besançon.
authors.forename: M
authors.initials: M
authors.lastname: Montard
authors.forename: C
authors.initials: C
authors.lastname: Chopin
authors.forename: B
authors.initials: B
authors.lastname: Delbosc
authors.forename: M
authors.initials: M
authors.lastname: Muhieddine
mesh_terms: D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D004008:Diclofenac / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D054018:Lasers, Excimer; D008297:Male; D009883:Ophthalmic Solutions; D010147:Pain Measurement; D018903:Photorefractive Keratectomy; D013748:Tetracaine / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000779:Anesthetics, Local; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009883:Ophthalmic Solutions; D013748:Tetracaine; D004008:Diclofenac